Actively Recruiting
Evaluation of the Effect of Systemic Proteolytic Enzyme Therapy on Postoperative Inflammatory Response and QoL After Surgical Extraction of Impacted Mandibular Third Molars
Led by University of Baghdad · Updated on 2024-05-08
55
Participants Needed
1
Research Sites
17 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
1. To compare the postoperative pain between the patients who receive the systemic enzyme therapy and patients in the control group in the third and seventh day. 2. To compare the postoperative swelling (edema) between the patients who receive the systemic enzyme therapy and patients in the control group in the third and seventh day. 3. To compare the degree of trismus between the patients who receive the systemic enzyme therapy and patients in the control group in the third and seventh day. 4. Measure patients' perceptions of changes in their quality of life in the postoperative period and compare it between the patients who receive the systemic enzyme therapy and patients in the control group in the third and seventh day.
CONDITIONS
Official Title
Evaluation of the Effect of Systemic Proteolytic Enzyme Therapy on Postoperative Inflammatory Response and QoL After Surgical Extraction of Impacted Mandibular Third Molars
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy patients over 18 years old of either gender
- Patients who have impacted mandibular third molar
- Ability to tolerate surgical procedure
- Pell and Gregory's classification (Class I and class II, position A and B)
You will not qualify if you...
- Patients with uncontrolled systemic diseases
- Patients with history of chemotherapy or radiotherapy therapy to the head and neck region
- Acute infection at the surgical site at time of operation
- The presence of cysts or tumors associated with the impacted teeth
- Pell and Gregory's classification (class III Position C)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Dunya Abdulmuniem Mahmood
Baghdad, Iraq, 10011
Actively Recruiting
Research Team
D
Dunya Abdulmuniem
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here